Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ced/llad218 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bovis calculus sativus improves cognitive function after ischemic stroke by regulating PKA/CREB/Sirt1/eIF2α signaling pathway.
J Ethnopharmacol
August 2025
School of Pharmaceutical Sciences, ZheJiang Chinese Medical University, Hangzhou, 310053, China. Electronic address:
Ethnopharmacological Relevance: Bovis calculus sativus (BCS) is a traditional medicinal agent known for its pharmacological properties, which include heat-clearing, mental faculty revitalization, liver-cooling, and anticonvulsant effects. It is widely used application in the treatment of ischemic stroke accompanied by cognitive impairment; however, further research is necessary to clarify its effects and underlying mechanisms.
Aim Of The Study: This study examined the therapeutic potential of BCS in mitigating ischemic stroke-induced cognitive impairment induced by ischemic stroke, focusing on its mechanism of action in enhancing synaptic plasticity via the PKA/CREB/Sirt1/eIF2α signaling pathway.
Acomys cahirinus develop lung stroma distortion but not fibrosis after bleomycin-induced injury.
Inflamm Regen
August 2025
Centre for Regenerative Medicine, Medical Research and Education Institute, Lomonosov Moscow State University, Moscow, 119234, Russia.
Background: Spiny mice (Acomys sp.) have a unique ability of scarless regeneration. Therefore, the transfer of models used in convenient laboratory mice to study fibrosis could be a prospective approach, enabling the identification of novel antifibrotic therapies.
View Article and Find Full Text PDFUnlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer's Disease: In Vivo, In Vitro, Histopathological, and Docking Studies.
Pharmaceuticals (Basel)
August 2025
Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11754, Egypt.
Alzheimer's disease (AD) is largely linked with oxidative stress, the accumulation of amyloid- plaques, and hyperphosphorylated -protein aggregation. Alterations in dopaminergic and serotonergic neurotransmission have also been implicated in various AD-related symptoms. : To explore new therapeutic agents, a series of bicyclic and tricyclic thieno-oxazepine derivatives were synthesized as potential acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors.
View Article and Find Full Text PDFA Robust HPLC Method for the Simultaneous Determination of Finerenone and Its Enantiomer Using AQbD.
Chirality
September 2025
Egyptian Drug Authority (EDA) formerly National Organization for Drug control and Research (NODCAR), Giza, Egypt.
The enantiomeric purity of Finerenone (FIN), a novel therapeutic for chronic kidney disease (CKD), is a critical quality attribute for ensuring patient safety. This study reports the first chiral HPLC method for the simultaneous determination of FIN and its enantiomer, developed and validated using a rigorous analytical quality by design (AQbD) framework. The method employs a CHIRALPAK AD-H column with an isocratic mobile phase of n-hexane: ethanol (62:38, v/v).
View Article and Find Full Text PDFDPGNet: A Boundary-Aware Medical Image Segmentation Framework Via Uncertainty Perception.
IEEE J Biomed Health Inform
August 2025
Addressing the critical challenge of precise boundary delineation in medical image segmentation, we introduce DPGNet, an adaptive deep learning model engineered to emulate expert perception of intricate anatomical edges. Our key innovations drive its superior performance and clinical utility, encompassing: 1) a three-stage progressive refinement strategy that establishes global context, performs hierarchical feature enhancement, and precisely delineates local boundaries; 2) a novel Edge Difference Attention (EDA) module that implicitly learns and quantifies boundary uncertainties without requiring explicit ground truth supervision; and 3) a lightweight, transformer-based architecture ensuring an exceptional balance between performance and computational efficiency. Extensive experiments across diverse and challenging medical image datasets demonstrate DPGNet's consistent superiority over state-of-the-art methods, notably achieving this with significantly lower computational overhead (25.
View Article and Find Full Text PDF